MSL
IMMU

Mackay Shields LLC’s Immunomedics Inc IMMU Stock Holding History

Mackay Shields LLC’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-39,600
Closed -$1.4M – 1606
2020
Q2 		$1.4M Sell
39,600
-83,396
-68% -$2.44M 0.01% 906
2020
Q1 		$1.66M Buy
122,996
+6,900
+6% +$116K 0.02% 749
2019
Q4 		$2.46M Sell
116,096
-23,600
-17% -$416K 0.02% 788
2019
Q3 		$1.85M Buy
139,696
+2,600
+2% +$38.2K 0.01% 928
2019
Q2 		$1.9M Buy
137,096
+90,391
+194% +$1.36M 0.01% 917
2019
Q1 		$897K Buy
46,705
+4,900
+12% +$79K 0.01% 1032
2018
Q4 		$597K Sell
41,805
-2,395
-5% -$47.5K ﹤0.01% 1101
2018
Q3 		$921K Buy
44,200
+4,600
+12% +$109K 0.01% 896
2018
Q2 		$938K Sell
39,600
-2,400
-6% -$48.2K 0.01% 972
2018
Q1 		$614K Buy
+42,000
New +$686K ﹤0.01% 1085

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Mackay Shields LLC's IMMU Position: Q3 2020 in Review

Mackay Shields LLC sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 39,600 shares — an estimated $1.4M sold.

Mackay Shields LLC first reported a position in IMMU in Q1 2018 and held it in 10 quarters. The position peaked at $2.46M in Q4 2019. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Mackay Shields LLC reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 39,600 Immunomedics Inc shares in Q3 2020, an estimated $1.4M.
  • Mackay Shields LLC first reported a position in Immunomedics Inc in Q1 2018 and held it in 10 quarters.
  • Mackay Shields LLC's Immunomedics Inc position peaked at $2.46M in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.